Tech Company Financing Transactions

Anaconda Biomed Funding Round

On 5/23/2017, Anaconda Biomed landed $168 million in Series A funding from Innogest Capital, Omega Funds and Ysios Capital.

Transaction Overview

Company Name
Anaconda Biomed
Announced On
5/23/2017
Transaction Type
Venture Equity
Amount
$168,000,009
Round
Series A
Investors

Innogest Capital (Lead Investor) (Giovanni Leo)

Omega Funds (Lead Investor) (Claudio Nessi)

Ysios Capital (Lead Investor) (Josep Sanfeliu)

Banco Sabadell

Proceeds Purpose
This financing provides Anaconda Biomed the capital necessary to substantially progress the development of our ANCD BRAIN device, including the validation and verification process, clinical studies to support the initial commercialization of ANCD BRAIN in Europe, and an initial submission to FDA.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Av. Alcalde Barnils 64-68 Mod. A P. 3 Sant Cugat del Vallés
Barcelona, 08174
Spain
Phone
+34 933 900 508
Website
www.anaconda.bio
Email Address
[email protected]
Overview
Anaconda Biomed is a Barcelona based medical device start-up co-founded by Dr. Marc Ribo and Dr. Ofir Arad. The company is developing the next generation of catheters to perform safely and efficiently mechanical thrombectomies.
Profile
Anaconda Biomed LinkedIn Company Profile
Social Media
Anaconda Biomed Company Twitter Account
Company News
Anaconda Biomed News
Facebook
Anaconda Biomed on Facebook
YouTube
Anaconda Biomed on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
François Salmon
  François Salmon LinkedIn Profile  François Salmon Twitter Account  François Salmon News  François Salmon on Facebook
Chief Marketing Officer
Lieven Huysse
  Lieven Huysse LinkedIn Profile  Lieven Huysse Twitter Account  Lieven Huysse News  Lieven Huysse on Facebook
Co-Founder
Ofir Arad
  Ofir Arad LinkedIn Profile  Ofir Arad Twitter Account  Ofir Arad News  Ofir Arad on Facebook
VP - Manufacturing
Jordi Cardona
  Jordi Cardona LinkedIn Profile  Jordi Cardona Twitter Account  Jordi Cardona News  Jordi Cardona on Facebook
VP - R & D
Iñaki Galve
  Iñaki Galve LinkedIn Profile  Iñaki Galve Twitter Account  Iñaki Galve News  Iñaki Galve on Facebook
VP - Regulatory Affairs
Juan Campos
  Juan Campos LinkedIn Profile  Juan Campos Twitter Account  Juan Campos News  Juan Campos on Facebook

 

 

Browse more venture capital transactions:

Prev: 5/23/2017: Echodyne venture capital transaction
Next: 5/23/2017: Symic Biomedical venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.